Beruflich Dokumente
Kultur Dokumente
Tumors can be benign or malignant. Tumors that stay in one spot and
demonstrate limited growth are generally considered to be benign. Malignant
cells are much “nimbler” than non-malignant ones. Malignant cells can pass
more easily through smaller gaps, as well as applying a much greater force on
their environment compared to other cells. Cells from malignant tumors can
invade nearby tissues. They can also break away and spread to other parts of
the body. Tumors can grow and interfere with the digestive, nervous, and
circulatory system, and they can release hormones that alter body function.
Cancer is a genetic disease which is caused by changes to genes that control
the way our cells function, especially how they grow and divide. Cells can
experience uncontrolled growth if there are mutations to DNA, and therefore,
alterations to the genes involved in cell division. The genetic changes that
contribute to cancer (usually called “drivers” of cancer) tend to affect the
following four main types of genes that are responsible for the cell division
process:
The spread of cancer from one part of the body to another is called metastasis,
resulting in a serious condition that is very difficult to treat. Symptoms and
treatment depend on the cancer type and how advanced it is.
Diagnosis
Most cancers are initially recognized either because of the appearance of signs
or symptoms or through screening. However, a definitive diagnosis requires the
examination of a tissue sample via pathology.
The tissue diagnosis from the biopsy indicates the type of cell that is
proliferating, its histological grade, genetic abnormalities and other features.
Cytogenetics and immunohistochemistry are other types of tissue tests. These
tests provide information about molecular changes (such as mutations, fusion
genes and numerical chromosome changes).
There are over 200 different types of cancer, and each is classified by the type
of cell that is initially affected. Here below, we have the following most recently
viewed cancer types covered in our development of diagnostic antibodies: